Skip to main content
Journal ArticleOPEN ACCESS

Sustained Long-Term MMR to a Reduced Dose of Imatinib in Chronic-Phase CML: A Pilot Study of SLC22A1 Gene Polymorphisms

  • Lee S
  • Lee S
  • Kim D
  • et al.
Blood (2012) 120(21) 4449-4449
DOI: 10.1182/blood.v120.21.4449.4449
N/ACitations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract 4449

Cite

CITATION STYLE

APA

Lee, S. R., Lee, S. Y., Kim, D. S., Park, Y., Sung, H. J., Choi, C. W., … Kim, B. S. (2012). Sustained Long-Term MMR to a Reduced Dose of Imatinib in Chronic-Phase CML: A Pilot Study of SLC22A1 Gene Polymorphisms. Blood, 120(21), 4449–4449. https://doi.org/10.1182/blood.v120.21.4449.4449

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free